Evidence map›Paper›PMID 30640445›Full record

ArticleBiochemistry2019

Human Glycerol 3-Phosphate Dehydrogenase: X-ray Crystal Structures That Guide the Interpretation of Mutagenesis Studies.

Lisa S Mydy, Judith R Cristobal, Roberto D Katigbak, Paul Bauer, Archie C Reyes, Shina Caroline Lynn Kamerlin, John P Richard, Andrew M Gulick

Abstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Structural insights into urocanate reductase using room-temperature X-ray crystallography.Acta crystallographica. Section D, Structural biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa S MydyDepartment of Structural Biology , University at Buffalo, SUNY , Buffalo , New York 14203 , United States.
Judith R CristobalDepartment of Chemistry , University at Buffalo, SUNY , Buffalo , New York 14260-3000 , United States.
Roberto D KatigbakDepartment of Chemistry , University at Buffalo, SUNY , Buffalo , New York 14260-3000 , United States.
Paul BauerScience for Life Laboratory, Department of Cell and Molecular Biology , Uppsala University , BMC Box 596, S-751 24 Uppsala , Sweden.
Archie C ReyesDepartment of Chemistry , University at Buffalo, SUNY , Buffalo , New York 14260-3000 , United States.ORCID 0000-0001-9955-393X
Shina Caroline Lynn KamerlinScience for Life Laboratory, Department of Cell and Molecular Biology , Uppsala University , BMC Box 596, S-751 24 Uppsala , Sweden.ORCID 0000-0002-3190-1173
John P RichardDepartment of Chemistry , University at Buffalo, SUNY , Buffalo , New York 14260-3000 , United States.ORCID 0000-0002-0440-2387
Andrew M GulickDepartment of Structural Biology , University at Buffalo, SUNY , Buffalo , New York 14203 , United States.ORCID 0000-0003-4238-7453

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
Development of HTP Assay for Inhibitors of Aerobactin ProductionR01AI116998 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI GULICK, ANDREW M · 2016 to 2018
$1.4M
Activation of Enzymes for Catalysis: The Role of Substrate-Induced Structural ChangesR01GM116921 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RICHARD, JOHN P · 2016 to 2019
$1.3M
NIAID NIH HHS R01 AI116998NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM116921NIH HHS S10 OD012289
6 · The paper itself

Abstract

Human liver glycerol 3-phosphate dehydrogenase ( hlGPDH) catalyzes the reduction of dihydroxyacetone phosphate (DHAP) to form glycerol 3-phosphate, using the binding energy associated with the nonreacting phosphodianion of the substrate to properly orient the enzyme-substrate complex within the active site. Herein, we report the crystal structures for unliganded, binary E·NAD, and ternary E·NAD·DHAP complexes of wild type hlGPDH, illustrating a new position of DHAP, and probe the kinetics of multiple mutant enzymes with natural and truncated substrates. Mutation of Lys120, which is positioned to donate a proton to the carbonyl of DHAP, results in similar increases in the activation barrier to hlGPDH-catlyzed reduction of DHAP and to phosphite dianion-activated reduction of glycolaldehyde, illustrating that these transition states show similar interactions with the cationic K120 side chain. The K120A mutation results in a 5.3 kcal/mol transition state destabilization, and 3.0 kcal/mol of the lost transition state stabilization is rescued by 1.0 M ethylammonium cation. The 6.5 kcal/mol increase in the activation barrier observed for the D260G mutant hlGPDH-catalyzed reaction represents a 3.5 kcal/mol weakening of transition state stabilization by the K120A side chain and a 3.0 kcal/mol weakening of the interactions with other residues. The interactions, at the enzyme active site, between the K120 side chain and the Q295 and R269 side chains were likewise examined by double-mutant analyses. These results provide strong evidence that the enzyme rate acceleration is due mainly or exclusively to transition state stabilization by electrostatic interactions with polar amino acid side chains.

Indexed as

MutationCatalytic DomainCrystallography, X-RayDihydroxyacetone PhosphateGlycerolphosphate DehydrogenaseGlycerophosphatesHumansLiverModels, MolecularMutagenesis, Site-DirectedProtein ConformationSubstrate Specificityalpha-glycerophosphoric acidDihydroxyacetone PhosphateGlycerolphosphate DehydrogenaseGlycerophosphates

Identifiers

PMID30640445
PMCPMC6450551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.